AI
AI-Designed Drug Shows Potential to Slow Biological Aging
Insilico Medicine's AI-generated drug Rentosertib showed a decrease in biological age markers for 43 patients in a clinical trial.
September 8, 2026, 11:57 AM·IT之家

Insilico Medicine's AI-generated drug Rentosertib showed a decrease in biological age markers for 43 patients in a clinical trial.

Insilico Medicine's AI-designed drug rentosertib showed signs of reversing biological aging markers in a trial with 42 patients.
